These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3885850)

  • 1. Lack of evidence for interaction between tobramycin and shock in their effect on renal function.
    Ambinder RF; Moore RD; Smith CR; Mellits ED; Lietman PS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):217-9. PubMed ID: 3885850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
    Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD; Smith CR; Holloway JJ; Lietman PS
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of risk factors for aminoglycoside nephrotoxicity.
    Smith CR; Moore RD; Lietman PS
    Am J Kidney Dis; 1986 Nov; 8(5):308-13. PubMed ID: 3538855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
    Moore RD; Smith CR; Lietman PS
    Am J Med; 1986 Jun; 80(6):1093-7. PubMed ID: 3728506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
    Gatell JM; SanMiguel JG; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta MT; Marin JL; Elena M; Ballesta A
    Nephron; 1985; 41(4):337-43. PubMed ID: 3906418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.
    Gatell JM; SanMiguel JG; Araujo V; Zamora L; Maña J; Ferrer M; Bonet M; Bohe M; Jimenez de Anta MT
    Antimicrob Agents Chemother; 1984 Nov; 26(5):766-9. PubMed ID: 6393868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Kuhlmann J; Seidel G; Grötsch H
    Infection; 1982; 10(4):233-9. PubMed ID: 6127319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
    Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
    J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
    [No Abstract]   [Full Text] [Related]  

  • 14. Is tobramycin less nephrotoxic than gentamicin?
    Burkle WS
    Clin Pharm; 1986 Jun; 5(6):514-6. PubMed ID: 3522055
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial.
    Moskowitz A; Andersen LW; Cocchi MN; Karlsson M; Patel PV; Donnino MW
    Ann Am Thorac Soc; 2017 May; 14(5):737-741. PubMed ID: 28207287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD; Smith CR; Lipsky JJ; Mellits ED; Lietman PS
    Ann Intern Med; 1984 Mar; 100(3):352-7. PubMed ID: 6364908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group.
    Slotman GJ; Fisher CJ; Bone RC; Clemmer TP; Metz CA
    Crit Care Med; 1993 Feb; 21(2):191-5. PubMed ID: 8428468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
    Alanis A; Rehm S; Weinstein AJ
    Cleve Clin Q; 1983; 50(4):385-95. PubMed ID: 6365358
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients.
    Hickling KG; Begg EJ; Perry RE; Atkinson HC; Sharman JR
    Crit Care Med; 1991 Aug; 19(8):1041-7. PubMed ID: 1860329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.